Skip to main content
Clinical Trials/NCT06230809
NCT06230809Not yet recruitingNot Applicable

Internet Based Self-help for Problem Gambling Concerned Significant Others

Karolinska Institutet0 sites170 target enrollmentStarted: March 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
170
Primary Endpoint
Kessler-9

Study Overview

Brief Summary

The project aims to evaluate a brief online self-help intervention for Concerned Significant Others of individuals with Problem Gambling. The intervention consists of five modules with texts, films and exercises and is compared to a waiting list.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •No treatment related to the gambling during the past 3 months for the CSO
  • •The CSO is at least 18 years old
  • •The CSO can read and answer questions in Swedish.
  • •The CSO is assessed as a non-problem gambler according to the Gambling Disorder Identification Test.

Exclusion Criteria

  • •Displaying symptoms of severe psychiatric disorders such as psychosis or bipolar disease deemed to needed other treatment options.

Arms & Interventions

Intervention

Experimental

Intervention: Web-based self-help (Behavioral)

Waitlist

No Intervention

Waitlist, participants will be included after 8 weeks.

Outcomes

Primary Outcomes

Kessler-9

Time Frame: At baseline and post treatment (5-7 weeks after inclusion) and again 3, 6, and 12 months following treatment completion

Mental health

Secondary Outcomes

  • Generalized Anxiety Disorder 7-item scale(At baseline and post treatment (5-7 weeks after inclusion), and again 3, 6, and 12 months following treatment completion)
  • Relationship Assessment Scale(At baseline and post treatment (5-7 weeks after inclusion), and again 3, 6, and 12 months following treatment completion)
  • Brunnsviken Brief Quality of life quality scale(At baseline and post treatment (5-7 weeks after inclusion), and again 3, 6, and 12 months following treatment completion)
  • Patient Health Questionnaire-9(At baseline and post treatment (5-7 weeks after baseline) and again 3, 6, and 12 months following treatment completion)
  • Family Member Impact Scale(At baseline and post treatment (5-7 weeks after inclusion), and again 3, 6, and 12 months following treatment completion)
  • Coping Questionnaire(At baseline and post treatment (5-7 weeks after inclusion), and again 3, 6, and 12 months following treatment completion)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Anders Nilsson

PhD

Karolinska Institutet

Similar Trials